This presentation will cover VitalDose’s role in patient centric delivery within Women’s Health, exploring how using the sustained release of single or multiple drugs can relieve patient burden in chronic diseases and provide a benefit to the formulation of small molecule API to larger molecule or complex therapeutics.
Improving the benchmark for measuring disease modification and reducing the use of symptomology is imperative for addressing underserved areas in women’s health such as ovarian cancer and endometriosis. This panel discussion will deep dive into the importance of prioritizing research through a sex & gender lens to identify new molecules, exploring the challenges and opportunities in investing in early-stage research, partnering with research institutions, and considering what more can be done.
Celia Lambert-Alcantara is Head of Sustainable finance and ESG Compliance at Crédit Agricole CIB, the investment bank of the French banking group Crédit Agricole.
With a master degree in political science, economics and international affairs, and an international background, Celia joined the banking industry almost 10 years ago. She joined the Crédit Agricole CIB back in 2015 and, after holding several roles within the compliance department, became Head of ESG Compliance in 2022. Her mission is to ensure that the Bank is compliant with the many European and international regulations on sustainable finance, addressing the greenwashing and ESG non-compliance risks through the implementation of supervision controls and effective advisory to the businesses. In order to address the ESG issues, the bank has launched a transversal ESG program, sponsored by the Top Management, that she is co-managing along with the sustainable banking business. She has been awarded “Leader of sustainability under 35” by the French think Tank HUB Institute.
